Elekta AB 

$6.1
21
-$0.2-3.17% Thursday 15:55

Statistics

Day High
6.1
Day Low
6.1
52W High
6.83
52W Low
4.48
Volume
900
Avg. Volume
637
Mkt Cap
2.25B
P/E Ratio
63.13
Dividend Yield
4.31%
Dividend
0.26

Upcoming

Dividends

4.31%Dividend Yield
Mar 26
$0.13
Sep 25
$0.13
Mar 25
$0.12
Sep 24
$0.12
Mar 24
$0.12
10Y Growth
24.6%
5Y Growth
15.8%
3Y Growth
5.46%
1Y Growth
6.39%

Earnings

5MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Next
0.03
0.06
0.1
0.14
Expected EPS
0.0486918068
Actual EPS
N/A

Financials

1.31%Profit Margin
Profitable
2019
2020
2021
2022
2023
2024
3.69BRevenue
48.34MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow EKTAF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic competes with Elekta in the neurosurgical market, offering products for brain surgeries and pain management that overlap with Elekta's Gamma Knife radiosurgery systems.
Intuitive Surgical
ISRG
Mkt Cap189.4B
Intuitive Surgical competes in the surgical space with robotic systems that, while not directly radiation therapy, offer alternative treatments for conditions Elekta's products also address.
Boston Scientific
BSX
Mkt Cap149.24B
Boston Scientific competes in the medical device market, particularly in neuromodulation, where its products can be seen as alternatives to Elekta's for certain conditions.
Smith & Nephew
SNN
Mkt Cap15.61B
Smith & Nephew competes in the advanced wound management and surgical devices market, indirectly competing with Elekta's offerings in surgical and oncology care.
Zimmer Biomet
ZBH
Mkt Cap19.92B
Zimmer Biomet competes in the musculoskeletal healthcare market, including surgical solutions that can indirectly compete with Elekta's products for certain therapeutic and diagnostic applications.
Stryker
SYK
Mkt Cap136.19B
Stryker competes across several medical device markets, including neurotechnology and spine, where its products can compete with Elekta's neurosurgical and radiosurgery offerings.
Globus Medical
GMED
Mkt Cap8.16B
Globus Medical competes in the spine and neurosurgery markets with products that can be alternatives to Elekta's solutions for spinal and brain conditions.
Abbvie
ABBV
Mkt Cap385.18B
AbbVie, through its acquisition of Allergan, competes in the neuroscience space, offering pharmaceutical alternatives to Elekta's device-based treatments for neurological conditions.
Johnson & Johnson
JNJ
Mkt Cap455.04B
Johnson & Johnson, through its medical devices division, competes in several areas including surgery and oncology, offering products that can be seen as alternatives to Elekta's radiation therapy and neurosurgery devices.

About

Elekta AB (publ), a medical technology company, provides clinical solutions for treating cancer and brain disorders worldwide. The company offers Versa HD, a brain metastases solution; Elekta Unity, a MR-Linac technology; Elekta Harmony, a linear accelerator; Elekta Infinity for treating a range of patients with simple-to-complex radiotherapy needs; Elekta Synergy, a digital accelerator for advanced image-guided radiation therapy; treatment management solutions; automated and integrated quality assurance solutions; and hardware and software motion management technology. It also provides MOSAIQ Plaza for multidisciplinary cancer care; Elekta Axis Cloud, a managed hosting service; Elekta Studio, an image-guided brachytherapy solution; ImagingRing, a mobile CT scanner; Oncentra Brachy, a smart tool that facilitate repetitive tasks; Venezia applicator that enables the radiation oncologist to treat locally advanced cervical cancer; Elekta Flexitron afterloader for enabling the precise execution of all steps in the workflow; and Geneva, an applicator for cervical cancer treatment. In addition, the company offers Leksell Gamma Knife Icon for personalized radiation treatment; Leksell Gamma Knife Perfexion, a tool for neurosurgeons; Leksell Gamma Knife Lightning for accelerated radiosurgery. Further, it provides neurosurgery products comprising Leksell Vantage Stereotactic System for intracranial neurosurgery; and Leksell Stereotactic System or minimally invasive stereotactic neurosurgery. The company was incorporated in 1972 and is headquartered in Stockholm, Sweden.
Show more...
CEO
Dr. Laurent Leksell
Employees
4541
Country
SE
ISIN
SE0000163628

Listings

0 Comments

Share your thoughts

FAQ

What is Elekta AB stock price today?
The current price of EKTAF is $6.1 USD — it has decreased by -3.17% in the past 24 hours. Watch Elekta AB stock price performance more closely on the chart.
What is Elekta AB stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Elekta AB stocks are traded under the ticker EKTAF.
Is Elekta AB stock price growing?
EKTAF stock has risen by +0% compared to the previous week, the month change is a +1.33% rise, over the last year Elekta AB has showed a +3.39% increase.
What is Elekta AB market cap?
Today Elekta AB has the market capitalization of 2.25B
When is the next Elekta AB earnings date?
Elekta AB is going to release the next earnings report on March 05, 2026.
What were Elekta AB earnings last quarter?
EKTAF earnings for the last quarter are 0.07 USD per share, whereas the estimation was 0.06 USD resulting in a +4.81% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Elekta AB revenue for the last year?
Elekta AB revenue for the last year amounts to 3.69B USD.
What is Elekta AB net income for the last year?
EKTAF net income for the last year is 48.34M USD.
Does Elekta AB pay dividends?
Yes, EKTAF dividends are paid semi-annual. The last dividend per share was 0.13 USD. As of today, Dividend Yield (FWD)% is 4.31%.
How many employees does Elekta AB have?
As of February 19, 2026, the company has 4,541 employees.
In which sector is Elekta AB located?
Elekta AB operates in the Health Care sector.
When did Elekta AB complete a stock split?
The last stock split for Elekta AB was on September 12, 2012 with a ratio of 4:1.
Where is Elekta AB headquartered?
Elekta AB is headquartered in Stockholm, SE.